{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:11:59Z","timestamp":1787699519465,"version":"build-2784847793"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"IPSEN Research Foundation"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011722","name":"Higher Education Funding Council for England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5,1]]},"DOI":"10.1373\/clinchem.2011.176099","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T23:47:39Z","timestamp":1330040859000},"page":"941-943","source":"Crossref","is-referenced-by-count":33,"title":["Quantifying the Effects of Renal Impairment on Plasma Concentrations of the Neuroendocrine Neoplasia Biomarkers Chromogranin A, Chromogranin B, and Cocaine- and Amphetamine-Regulated Transcript"],"prefix":"10.1093","volume":"58","author":[{"given":"Paul R","family":"Bech","sequence":"first","affiliation":[{"name":"Section of Investigative Medicine Imperial College London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha","family":"Ramachandran","sequence":"first","affiliation":[{"name":"Section of Investigative Medicine Imperial College London, UK"},{"name":"Endocrine Unit and"},{"name":"Clinical Biochemistry Imperial College Healthcare NHS Trust London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waljit S","family":"Dhillo","sequence":"first","affiliation":[{"name":"Section of Investigative Medicine Imperial College London, UK"},{"name":"Endocrine Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh M","family":"Martin","sequence":"first","affiliation":[{"name":"Section of Investigative Medicine Imperial College London, UK"},{"name":"Endocrine Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R","family":"Bloom","sequence":"first","affiliation":[{"name":"Section of Investigative Medicine Imperial College London, UK"},{"name":"Endocrine Unit and"},{"name":"Clinical Biochemistry Imperial College Healthcare NHS Trust London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,5,1]]},"reference":[{"key":"2020022705125230800_B1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00423-011-0739-1","article-title":"The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors","volume":"396","author":"Schimmack","year":"2011","journal-title":"Langenbecks Arch Surg"},{"key":"2020022705125230800_B2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ecl.2010.12.001","article-title":"The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020022705125230800_B3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.regpep.2006.10.008","article-title":"Measurements of chromogranin B can serve as a complement to chromogranin A","volume":"139","author":"Stridsberg","year":"2007","journal-title":"Regul Pept"},{"key":"2020022705125230800_B4","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1210\/jc.2007-1946","article-title":"Elevated cocaine- and amphetamine-regulated transcript immunoreactivity in the circulation of patients with neuroendocrine malignancy","volume":"93","author":"Bech","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022705125230800_B5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5414\/CNP71244","article-title":"Prevalence of chronic kidney disease: a systematic review and meta-analysis","volume":"71","author":"Anothaisintawee","year":"2009","journal-title":"Clin Nephrol"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/58\/5\/941\/32657635\/clinchem0941.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/58\/5\/941\/32657635\/clinchem0941.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T05:14:18Z","timestamp":1582780458000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/58\/5\/941\/5620646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,1]]},"references-count":5,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,1]]},"published-print":{"date-parts":[[2012,5,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2011.176099","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,5,1]]},"published":{"date-parts":[[2012,5,1]]}}}